Plaquenil Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

  • Single User License $3500

Plaquenil Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Status : May, 2021 | Healthcare IT

Report Digest

Plaquenil drug, brand name of Hydroxychloroquine, is a disease modifying anti-rheumatic drug. It eases the pain and swelling of arthritis. It helps in preventing joint damage and reduces the risk of long- term disability. Rheumatoid arthritis, symptoms of lupus, and childhood arthritis can be treated by taking plaquenil drugs. The drug can also prevent diseases caused by parasites.

The global plaquenil drug market is expected to grow at a CAGR between 6-9%. The growth rate is expected to double during the forecast period 2021-2031.

Prevalence of Malaria and Coronavirus

Malaria, transmitted through a mosquito bite is a life- threatening disease and its prevalence in various countries has led to increased demand of plaquenil drug. Rising concerns about health due to infectious and autoimmune diseases spreading all over the world are some factors driving the growth of the palquenil drugs market.

Side effects of the Drug may hamper the Growth

Skin rashes, feeling sick, diarrhoea, headaches, hair loss, visual problems are some of the side effects that can prevail after taking higher dose of plaquein drug. There is a small risk that plquenil drug can damage the internal part of retina in case of long term use. These side –effects can cause a long term permanent problem among patients and thus, may restrain the growth of the market.

Plaquenil Drugs Market- Competitive Market

Key manufacturers for the plaquenil drug are:

  • Cadila Healthcare Ltd
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd
  • Mylan N.V
  • Novartis AG
  • Pfizer Inc
  • Sanofi S.A.
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceuticals Industries
  • Zydus Cadila
  • Torrent Pharmaceuticals

In March 2020, a well renowned drug firm Cadila health care announced their approval for transferring their animal health care business to its wholly-owned firm Zydus Animal Health and Investments Ltd. as part of its internal restructuring exercise.

In March 2020, owing to the fear of pandemic, Novartis committed to donate 130 million doses of plaquenil drug (or hydroxychloroquine). The company is further exploring to scale its supply and tried working with manufacturers to meet the global demand. 

Pfizer and BioNTech announced development of vaccine against the global pandemic Covid-19. The vaccine has been authorized for use by FDA to prevent the spread of disease any further.

Plaquenil Drugs Market- Regional Outlook

Asia-Pacific dominates the plaquenil drug market owing to presence of major players like India and China in the region, India being the largest supplier of pharmaceuticals in the world. Furthermore, surge in demand for medication due to high rate of increasing malaria, coronavirus, arthritis, etc. Rise in geriatric population among Japan and India is also the key growth prospect for this region.  

Plaquenil Drugs Market- Segmentation

Based on Product Type

  • Tablet
  • Active pharmaceutical ingredients

Based on Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Specialty Drug Store
  • Retail Pharmacy

By Disease

  • Malaria
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Coronavirus
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America

Key Questions Answered

  • Which segment to grow the plaquenil drug sector during the forecast period?

    Although covid-19 has been contained in some countries with vaccine and lockdowns but according to WHO, the disease is not vanishing anytime soon. It paves a way of growth for the drug.

  • Which end-user segment is the highest market for plaquenil drug?

    Hospital Pharmacy to account for dominant share owing to rising government initiatives for treating malaria in rural areas of developing and under developing nations.

  • Which country holds the largest manufacturers of palquenil drugs?

    India is the largest manufacturers of drugs or medicines in the World. Several countries depend on India for pharmaceutical requirements.

  • What are the key factors driving the global market?

    Outbreak of covid-19 and increasing malaria cases are the key growth prospects in the world.

  • Which are the prominent manufacturers in the market?

    Ipca Laboratories Ltd, Mylan N.V, Novartis AG, Pfizer Inc, etc. are the prominent players focussing and investing on research and development.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?